Data / Form D filings / Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc.: Form D filings
Seneca Therapeutics, Inc., a pharmaceuticals company in Blue Bell, PA, filed 9 Form D notices with the SEC between 2019 and 2025. The latest, on February 7, 2025, reports $1.6 million sold of a $8 million offering to 68 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 202 ST. ANDREWS COURT, Blue Bell, PA, 19422
- Phone
- (484) 883-9725
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1778151
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | New notice | $8,000,000 | $1,636,582 | $6,363,418 | 68 | Dec 16, 2024 | sec.gov |
| Dec 23, 2022 | Amendment | $12,800,000 | $7,711,958 | $5,088,042 | 114 | Mar 12, 2021 | sec.gov |
| Dec 22, 2021 | Amendment | $10,000,000 | $4,996,635 | $5,003,365 | 79 | Mar 12, 2021 | sec.gov |
| Apr 2, 2021 | New notice | $5,000,000 | $726,869 | $4,273,131 | 34 | Mar 12, 2021 | sec.gov |
| Jun 23, 2020 | New notice | $3,250,000 | $500,999 | $2,749,001 | 15 | Jun 12, 2020 | sec.gov |
| Mar 19, 2020 | Amendment | $1,000,000 | $820,000 | $180,000 | 14 | Mar 12, 2020 | sec.gov |
| Nov 22, 2019 | New notice | $750,000 | $65,000 | $685,000 | 2 | Nov 14, 2019 | sec.gov |
| Aug 8, 2019 | Amendment | $500,000 | $380,000 | $120,000 | 7 | May 15, 2019 | sec.gov |
| May 30, 2019 | New notice | $350,000 | $55,000 | $295,000 | 2 | May 15, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cuong Do | Executive Officer, Director | |
| Mark Kerschner | Director | |
| Paul Hallenbeck | Executive Officer, Director | |
| James Hussey | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Feb 3, 2025 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Seneca Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.